These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3296152)

  • 21. Improvement of lacrimal function by topical application of CyA in murine models of Sjögren's syndrome.
    Tsubota K; Fujita H; Tadano K; Takeuchi T; Murakami T; Saito I; Hayashi Y
    Invest Ophthalmol Vis Sci; 2001 Jan; 42(1):101-10. PubMed ID: 11133854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Etanercept in the treatment of patients with primary Sjögren's syndrome: a pilot study.
    Zandbelt MM; de Wilde P; van Damme P; Hoyng CB; van de Putte L; van den Hoogen F
    J Rheumatol; 2004 Jan; 31(1):96-101. PubMed ID: 14705226
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The point on the ongoing B-cell depleting trials currently in progress over the world in primary Sjögren's syndrome.
    Saraux A
    Autoimmun Rev; 2010 Jul; 9(9):609-14. PubMed ID: 20452466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rituximab treatment in patients with primary Sjögren's syndrome: an open-label phase II study.
    Pijpe J; van Imhoff GW; Spijkervet FK; Roodenburg JL; Wolbink GJ; Mansour K; Vissink A; Kallenberg CG; Bootsma H
    Arthritis Rheum; 2005 Sep; 52(9):2740-50. PubMed ID: 16142737
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical trial of ambroxol (Mucosolvan) in Sjögren's syndrome.
    Ichikawa Y; Tokunaga M; Shimizu H; Moriuchi J; Takaya M; Arimori S
    Tokai J Exp Clin Med; 1988 Aug; 13(3):165-9. PubMed ID: 2978189
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sjögren's syndrome - not just Sicca: renal involvement in Sjögren's syndrome.
    Kaufman I; Schwartz D; Caspi D; Paran D
    Scand J Rheumatol; 2008; 37(3):213-8. PubMed ID: 18465457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral pilocarpine for symptomatic relief of keratoconjunctivitis sicca in patients with Sjögren's syndrome. The MGI PHARMA Sjögren's Syndrome Study Group.
    Nelson JD; Friedlaender M; Yeatts RP; Yee R; McDermott M; Orlin S; Gallagher SC; Shrotriya RC
    Adv Exp Med Biol; 1998; 438():979-83. PubMed ID: 9634998
    [No Abstract]   [Full Text] [Related]  

  • 28. Treatment of primary Sjögren's syndrome with low-dose human interferon alfa administered by the oromucosal route: combined phase III results.
    Cummins MJ; Papas A; Kammer GM; Fox PC
    Arthritis Rheum; 2003 Aug; 49(4):585-93. PubMed ID: 12910567
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Bilateral optic neuropathy disclosing primary Gougerot-Sjögren syndrome].
    Rapoport P; Merle H; Smadja D; Gerard M; Alliot E
    J Fr Ophtalmol; 1997; 20(10):767-70. PubMed ID: 9587591
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Autoimmune hepatitis in primary Sjogren's syndrome: pathological study of the livers and labial salivary glands in 17 patients with primary Sjogren's syndrome.
    Matsumoto T; Morizane T; Aoki Y; Yamasaki S; Nakajima M; Enomoto N; Kobayashi S; Hashimoto H
    Pathol Int; 2005 Feb; 55(2):70-6. PubMed ID: 15693852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prominent adverse effects of thalidomide in primary Sjögren's syndrome.
    Pillemer SR; Leakan RA; Sankar V; Manny J; Baum BJ; Smith J; Chaudhry U; Fox PC; Radfar L; Ligier S; Brennan MT
    Arthritis Rheum; 2004 Jun; 51(3):505-6. PubMed ID: 15188341
    [No Abstract]   [Full Text] [Related]  

  • 32. Minor salivary gland immunohistology in the diagnosis of primary Sjögren's syndrome.
    Salomonsson S; Rozell BL; Heimburger M; Wahren-Herlenius M
    J Oral Pathol Med; 2009 Mar; 38(3):282-8. PubMed ID: 18793250
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Proposed core set of outcome measures in patients with primary Sjögren's syndrome: 5 year follow up.
    Theander E; Andersson SI; Manthorpe R; Jacobsson LT
    J Rheumatol; 2005 Aug; 32(8):1495-502. PubMed ID: 16078325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Saliva substitute in xerostomic patients with primary Sjögren's syndrome: a single-blind trial.
    Alves MB; Motta AC; Messina WC; Migliari DA
    Quintessence Int; 2004 May; 35(5):392-6. PubMed ID: 15130080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren's syndrome.
    Rihl M; Ulbricht K; Schmidt RE; Witte T
    Rheumatology (Oxford); 2009 Jul; 48(7):796-9. PubMed ID: 19433433
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Interferon alpha (IFNalpha) treatment for Sjögren's syndrome].
    Shiozawa K; Shiozawa S
    Nihon Rinsho; 2006 Jul; 64(7):1345-53. PubMed ID: 16838655
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lamivudine is not effective in primary Sjögren's syndrome.
    Gescuk B; Wu AJ; Whitcher JP; Daniels TE; Lund S; Fye K; Davis JC
    Ann Rheum Dis; 2005 Sep; 64(9):1326-30. PubMed ID: 15708886
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Transient, prolonged, combined sicca syndrome of the eyes and mouth. Occurrence along with a common cold in an 8-year-old girl].
    Rebmann H; Rohrbach JM; Riester A
    Monatsschr Kinderheilkd; 1992 Aug; 140(8):457-9. PubMed ID: 1435804
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and safety of rebamipide for the treatment of dry mouth symptoms in patients with Sjögren's syndrome: a double-blind placebo-controlled multicenter trial.
    Sugai S; Takahashi H; Ohta S; Nishinarita M; Takei M; Sawada S; Yamaji K; Oka H; Umehara H; Koni I; Sugiyama E; Nishiyama S; Kawakami A
    Mod Rheumatol; 2009; 19(2):114-24. PubMed ID: 19089532
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Single-blinded controlled trial of low-dose oral IFN-alpha for the treatment of xerostomia in patients with Sjögren's syndrome.
    Shiozawa S; Tanaka Y; Shiozawa K
    J Interferon Cytokine Res; 1998 Apr; 18(4):255-62. PubMed ID: 9568728
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.